Laboratory of Bioenergetics, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.
Physiol Res. 2024 Aug 31;73(Suppl 1):S243-S278. doi: 10.33549/physiolres.935407. Epub 2024 Jul 17.
Disorders of ATP synthase, the key enzyme in mitochondrial energy supply, belong to the most severe metabolic diseases, manifesting as early-onset mitochondrial encephalo-cardiomyopathies. Since ATP synthase subunits are encoded by both mitochondrial and nuclear DNA, pathogenic variants can be found in either genome. In addition, the biogenesis of ATP synthase requires several assembly factors, some of which are also hotspots for pathogenic variants. While variants of MT-ATP6 and TMEM70 represent the most common cases of mitochondrial and nuclear DNA mutations respectively, the advent of next-generation sequencing has revealed new pathogenic variants in a number of structural genes and TMEM70, sometimes with truly peculiar genetics. Here we present a systematic review of the reported cases and discuss biochemical mechanisms, through which they are affecting ATP synthase. We explore how the knowledge of pathophysiology can improve our understanding of enzyme biogenesis and function. Keywords: Mitochondrial diseases o ATP synthase o Nuclear DNA o Mitochondrial DNA o TMEM70.
三磷酸腺苷合酶(ATP synthase)是线粒体能量供应的关键酶,其相关病变属于最严重的代谢性疾病,以早发型线粒体脑肌病为主要表现。由于 ATP 合酶亚基的编码基因同时存在于线粒体 DNA 和核 DNA 中,因此致病突变既可见于线粒体基因组,也可见于核基因组。此外,ATP 合酶的生物合成还需要多种组装因子的参与,其中一些因子也是致病突变的热点。MT-ATP6 和 TMEM70 的突变分别是线粒体和核 DNA 突变中最常见的类型,而新一代测序技术的出现则揭示了许多结构基因和 TMEM70 中存在新的致病突变,这些突变的遗传学特征有时非常特殊。本文对已报道的病例进行了系统回顾,并讨论了这些突变影响 ATP 合酶的生化机制,同时还探讨了病理生理学知识如何帮助我们加深对酶生物合成和功能的理解。关键词:线粒体疾病;ATP 合酶;核 DNA;线粒体 DNA;TMEM70。